BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24617620)

  • 1. CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.
    Annborn M; Dankiewicz J; Nielsen N; Rundgren M; Smith JG; Hertel S; Struck J; Friberg H
    Acta Anaesthesiol Scand; 2014 Apr; 58(4):428-36. PubMed ID: 24617620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients.
    Broessner G; Hasslacher J; Beer R; Lackner P; Lehner GF; Harler U; Schiefecker A; Helbok R; Pfausler B; Hammerer-Lercher A; Joannidis M
    Resuscitation; 2015 Apr; 89():75-80. PubMed ID: 25619444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combination of Biomarkers for Prognostication of Long-Term Outcome in Patients Treated with Mild Hypothermia After Out-of-Hospital Cardiac Arrest-A Pilot Study.
    Annborn M; Nilsson F; Dankiewicz J; Rundgren M; Hertel S; Struck J; Cronberg T; Nielsen N
    Ther Hypothermia Temp Manag; 2016 Jun; 6(2):85-90. PubMed ID: 26977736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
    Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F
    Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
    Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.
    Krüger S; Papassotiriou J; Marre R; Richter K; Schumann C; von Baum H; Morgenthaler NG; Suttorp N; Welte T;
    Intensive Care Med; 2007 Dec; 33(12):2069-78. PubMed ID: 17938883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department.
    Nickel CH; Ruedinger J; Misch F; Blume K; Maile S; Schulte J; Köhrle J; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2011 Aug; 18(8):851-9. PubMed ID: 21843221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M
    J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Frechen D; Rohde G; Suttorp N; Welte T;
    Respir Med; 2014 Nov; 108(11):1696-705. PubMed ID: 25306251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
    Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular biomarkers in preeclampsia at triage.
    Wellmann S; Benzing J; Fleischlin S; Morgenthaler N; Fouzas S; Bührer CA; Szinnai G; Burkhardt T; Lapaire O
    Fetal Diagn Ther; 2014; 36(3):202-7. PubMed ID: 24853905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
    Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
    Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
    Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.
    Koch L; Dabek MT; Frommhold D; Poeschl J
    Horm Res Paediatr; 2011; 76(4):234-9. PubMed ID: 21893934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin after cardiac arrest - an indicator of severity of illness, ischemia-reperfusion injury and outcome.
    Annborn M; Dankiewicz J; Erlinge D; Hertel S; Rundgren M; Smith JG; Struck J; Friberg H
    Resuscitation; 2013 Jun; 84(6):782-7. PubMed ID: 23313427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.
    Miller WL; Hartman KA; Grill DE; Struck J; Bergmann A; Jaffe AS
    Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: emerging role of CT-proET-1.
    Silva Marques J; Martins SR; Calisto C; Gonçalves S; Almeida AG; de Sousa JC; Pinto FJ; Diogo AN
    J Heart Lung Transplant; 2013 Dec; 32(12):1214-21. PubMed ID: 23916896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C
    Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.